OAC
HRMY icon

OMERS Administration Corp’s Harmony Biosciences HRMY Stock Holding History

OMERS Administration Corp’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$868K Buy
30,990
+18,300
+144% +$600K 0.01% 684
2025
Q4 		$475K Buy
12,690
+1,490
+13% +$49K ﹤0.01% 675
2025
Q3 		$309K Buy
+11,200
New +$386K ﹤0.01% 873

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

OMERS Administration Corp's HRMY Position: Q1 2026 in Review

OMERS Administration Corp increased its Harmony Biosciences (HRMY) stake by 144% in Q1 2026, buying an estimated $600K and bringing the position to 30,990 shares worth $868K. The position accounts for 0.01% of the portfolio, ranked #684.

OMERS Administration Corp first reported a position in HRMY in Q3 2025 and has held it in 3 quarters since. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • OMERS Administration Corp held 30,990 shares of Harmony Biosciences worth $868K as of Q1 2026.
  • OMERS Administration Corp bought 18,300 Harmony Biosciences shares in Q1 2026, an estimated $600K.
  • Harmony Biosciences made up 0.01% of OMERS Administration Corp's portfolio in Q1 2026, its #684 holding.
  • OMERS Administration Corp first reported a position in Harmony Biosciences in Q3 2025 and has held it in 3 quarters since.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on OMERS Administration Corp's 13F filing for Q1 2026, filed 15 May 2026.